These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 14224648)

  • 21. STUDIES ON THE ADMINISTRATION OF STREPTOKINASE. A METHOD TO OBTAIN THROMBOLYTIC EFFECT WITHOUT EXCESSIVE FIBRINOGENOLYSIS.
    HELLE I; AAS K; GODAL HC
    Sangre (Barc); 1964; 38():167-74. PubMed ID: 14217607
    [No Abstract]   [Full Text] [Related]  

  • 22. INHIBITION OF FIBRINOLYSIS AND FIBRINOGENOLYSIS IN MAN: COMPARISON OF EPILSON-AMINOCAPROIC AID AND KALLIKREIN INHIBITOR.
    BECK E; SCHMUTZLER R; DUCKERT F
    Thromb Diath Haemorrh; 1963 Nov; 10():106-19. PubMed ID: 14081273
    [No Abstract]   [Full Text] [Related]  

  • 23. SOME PROPERTIES OF THE ANTIFIBRINOLYTICALLY ACTIVE ISOMER OF AMINO-METHYLCYCLOHEXANE CARBOXYLIC ACID.
    DUBBER AH; MCNICOL GP; DOUGLAS AS; MELANDER B
    Lancet; 1964 Dec; 2(7373):1317-9. PubMed ID: 14224037
    [No Abstract]   [Full Text] [Related]  

  • 24. ENHANCING BLOOD FIBRINOLYTIC ACTIVITY BY A NIACIN COMPOUND. II. ACTIVATION AND NONACTIVATION.
    AMERY A; VERMYLEN J; DEVREKER RA; VERMYLEN C
    Am J Med Sci; 1965 Jan; 249():66-71. PubMed ID: 14254831
    [No Abstract]   [Full Text] [Related]  

  • 25. [COMPARATIVE STUDIES ON FIBRINOLYSIS ACTIVATED BY UROKINASE AND STREPTOKINASE IN HUMANS AND DOGS].
    BOROS M; BARANKAY A; SIMON L
    Med Pharmacol Exp Int J Exp Med; 1965; 12():184-9. PubMed ID: 14283800
    [No Abstract]   [Full Text] [Related]  

  • 26. THE ROLE OF FIBRINOLYSIS IN THE TREATMENT OF ARTERIAL THROMBOSIS: EXPERIMENTAL AND CLINICAL ASPECTS.
    TSAPOGAS MJ
    Ann R Coll Surg Engl; 1964 May; 34(5):293-313. PubMed ID: 14145330
    [No Abstract]   [Full Text] [Related]  

  • 27. INTRAVASCULAR CLOTTING AND SPONTANEOUS FIBRINOLYSIS.
    KOLLER F
    Acta Haematol; 1964 Apr; 31():239-46. PubMed ID: 14169390
    [No Abstract]   [Full Text] [Related]  

  • 28. QUANTITATIVE ESTIMATION OF UROKINASE AND BACTERIAL PLASMINOGEN ACTIVATORS USING A FIBRIN SUBSTRATE FORMED FROM PLASMINOGEN-FREE FIBRINOGEN.
    ANDERSON AJ
    Biochim Biophys Acta; 1963 Aug; 74():554-7. PubMed ID: 14071603
    [No Abstract]   [Full Text] [Related]  

  • 29. THE FIBRINOLYTIC SYSTEM DURING THE MENSTRUAL CYCLE.
    BELLER FK; GOEBELSMANN U; DOUGLAS GW; JOHNSON A
    Obstet Gynecol; 1964 Jan; 23():12-6. PubMed ID: 14110046
    [No Abstract]   [Full Text] [Related]  

  • 30. [EFFECT OF INCREASED FIBRINOLYSIS ON PLASMA FIBRINOGEN; A HYPOTHESIS CONCERNING THE ORIGIN OF AFIBRINOGENEMIA].
    DE WIT CD; MOERS AM; DEN OTTOLANDERGJ
    Ned Tijdschr Geneeskd; 1964 Aug; 108():1482-5. PubMed ID: 14182799
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of dog fibrinolytic system in experimental tubular necrosis of kidney.
    Niewiarowski S; Prokopowicz J; Poplawski A; Worowski K
    Experientia; 1964 Feb; 20(2):101-3. PubMed ID: 5852151
    [No Abstract]   [Full Text] [Related]  

  • 32. THE FIBRINOLYTIC SYSTEM IN HEALTH AND DISEASE.
    JOHNSON AJ; NEWMAN J
    Semin Hematol; 1964 Oct; 1():401-31. PubMed ID: 14225683
    [No Abstract]   [Full Text] [Related]  

  • 33. [TECHNIC FOR THE PREPARATION OF A FIBRINOGEN REAGENT FOR DETERMINATIONS OF FIBRINOLYTIC ACTIVITY].
    BLATRIX C; VIGNAL A; STEINBUCH M
    Hemostase; 1963; 3():179-86. PubMed ID: 14050814
    [No Abstract]   [Full Text] [Related]  

  • 34. THE FIBRINOLYTIC SYSTEM IN BLOOD AFTER RETENTION OF A DEAD FETUS AND DURING NORMAL LABOR.
    BRAKMAN P; KING AE
    Am J Obstet Gynecol; 1965 May; 92():221-6. PubMed ID: 14281832
    [No Abstract]   [Full Text] [Related]  

  • 35. [EXPERIMENTAL CONTRIBUTIONS TO THE DETERMINATION OF THE EFFICIENCY OF METHODS OF STUDYING COAGULATION PHYSIOLOGY. III. ACTIVATION OF THE PROFIBRINOLYTIC SYSTEM BY 2 DIFFERENT STREPTOKINASE PREPARATIONS AND THE STORAGE STABILITY OF ITS COMPONENTS].
    BERGHOFF A; GLATZEL H
    Thromb Diath Haemorrh; 1963 Jul; 143():436-45. PubMed ID: 14081265
    [No Abstract]   [Full Text] [Related]  

  • 36. A RAPID SCREENING METHOD FOR DEMONSTRATING FIBRINOLYSIS DURING SURGICAL OPERATIONS.
    BOTTEMA JK; VERVOORT HJ
    Clin Chim Acta; 1964 Feb; 9():179-82. PubMed ID: 14122507
    [No Abstract]   [Full Text] [Related]  

  • 37. IMMUNOHISTOCHEMICAL STUDY OF THROMBOLYTIC MECHANISMS.
    BACK N; HIRAMOTO R; AMBRUS JL
    Blood; 1965 Jun; 25():1028-36. PubMed ID: 14294764
    [No Abstract]   [Full Text] [Related]  

  • 38. THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS.
    TICE DA; WORTH MH; CLAUSS RH; REED GH
    Surg Gynecol Obstet; 1964 Jul; 119():71-4. PubMed ID: 14179354
    [No Abstract]   [Full Text] [Related]  

  • 39. [THE FIBRINOLYTIC THERAPY OF EXPERIMENTAL MASSIVE PULMONARY EMBOLISM IN RABBITS].
    MATTIOLI G; RABITTI G; NAVA C
    Minerva Cardioangiol; 1964 Jan; 12():25-8. PubMed ID: 14130219
    [No Abstract]   [Full Text] [Related]  

  • 40. THE EFFECT OF CALCIUM OF FIBRINOLYSIS IN VITRO.
    BRUCE S
    J Clin Pathol; 1964 May; 17(3):282-6. PubMed ID: 14159461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.